Unavailability of Witness for Cross-Examination Dooms Reliance on Affidavit Testimony in PTAB Proceeding

Nov 23, 2021

Reading Time : 2 min

By: Matthew George Hartman, Rubén H. Muñoz, Megan Mahoney (Law Clerk)

The petitioner challenged several patents, all related to methods and devices used to open and remove tissue from a patient’s eye. In support of its petitions, the petitioner submitted a 1984 article that discusses a surgical method for opening or tearing the trabecular meshwork of an eye.

After the PTAB instituted review, the patent owner submitted a sworn affidavit from the named author of the 1984 article to clarify what the article was meant to report. However, upon the petitioner’s request to cross-examine the witness, the patent owner was unable to produce him. The witness—an 85-year-old, retired Spanish citizen residing in Spain—was unwilling to travel to the United States for a deposition because of health concerns and the COVID-19 pandemic. The PTAB instructed the parties to further cooperate and depose the witness in Spain, but the witness eventually stated he did not wish to be involved in the dispute beyond his previous affidavit.

The petitioner then moved to strike the affidavit, arguing that its inability to cross-examine the witness would cause extreme prejudice, as the affidavit attempted to contradict and rewrite portions of the 1984 article. In response, the patent owner argued that the affidavit is not dispositive to the issues in dispute, and therefore something less than a live deposition would be a suitable alternative for the petitioner. The patent owner further advocated that, rather than strike the evidence, the PTAB should simply accord the appropriate weight to the affidavit in light of having no cross-examination.

The PTAB ultimately agreed with the petitioner, determining that it would be improper to consider the affidavit without the patent owner making the witness available for cross-examination. The PTAB explained that routine discovery requires that parties make their witnesses available for cross-examination if they want to proffer testimony by affidavit. See 37 C.F.R. §§ 42.51–42.53. The PTAB’s Consolidated Trial Practice Guide further clarifies that “[d]iscovery is a tool to develop a fair record and to aid [the PTAB] in assessing the credibility of a witness,” and therefore a party seeking to present testimony by affidavit must make the witness available for cross-examination. Because allowing the affidavit to remain in evidence without cross-examination would not provide a fair record and would prevent the PTAB from assessing the witness’s credibility, the PTAB granted the petitioner’s motion to strike the affidavit from each of the proceedings.

Practice Tip: To introduce and rely on sworn affidavits as evidence in an inter partes review proceeding, parties should be prepared to make those witnesses available for cross-examination. Failure to do so may have profound consequences on the merits of the proceeding, such as the PTAB striking evidence from the record and according no weight to briefing that relies on such evidence. While extenuating circumstances may elicit some flexibility from the PTAB, it does not relieve a party of its duty to produce a witness for cross-examination.

New World Medical, Inc. v. Microsurgical Tech., Inc., IPR2020-01573, Paper 49 (PTAB Nov. 5, 2021).

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.